There was an increase in the frequency of PD-1+/DNAM-1+ CD4+ and CD8+ T cells in AML recipients compared to naïve spleen, indicating an expansion of effector T cells with reduced cytotoxic potential (Fig. 3F, Supplementary Fig. 5A–D). The gene discussed is CD8A; the disease is acute myeloid leukemia.